Skip to main content
. 2018 Jan 24;56(2):e00787-17. doi: 10.1128/JCM.00787-17

TABLE 2.

Sensitivity of PUA test by serotype

Category and serotypea Total no. of isolates Sensitivity (%) P valueb
Overall 1,096 72.0
PCV7 181 84.0 0.000
    4 17 82.4 0.424
    6B 16 75.0 1.000
    9V 32 90.6 0.017
    14 53 86.8 0.014
    18C 11 100.0 0.041
    19F 41 78.0 0.378
    23F 11 72.7 1.000
Additional PCV13 500 74.6 0.078
    1 77 79.2 0.143
    3 226 69.0 0.266
    5 22 68.2 0.688
    6A 7 85.7 0.680
    7F 79 81.0 0.064
    19A 89 79.8 0.088
PCV13 681 77.1 0.000
Non-PCV13 415 63.6 <0.001
    6C 21 66.7 0.583
    8 29 55.2 0.041
    9L/N 23 39.1 0.000
    10A 12 66.7 0.748
    11A 41 48.8 0.001
    12F 30 79.3 0.563
    15A 16 87.5 0.260
    15B 7 85.7 0.680
    15C 5 60.0 0.623
    16F 25 64.0 0.368
    17F 8 87.5 0.455
    20 3 100.0 0.564
    21 4 50.0 0.313
    22F 30 66.7 0.510
    23A 19 68.4 0.727
    23B 9 33.3 0.018
    24F 18 55.6 0.117
    31 21 71.4 0.954
    33F 14 85.7 0.372
    35F 7 57.1 0.380
    35B 15 73.3 0.907
    NTc 23 47.8 0.009
    Other 35 68.6 0.647
a

PCV7, serotypes included in PCV7; additional PCV13, serotypes not included in PCV7 and included in PCV13; non-PCV13, serotypes not included in PCV13.

b

Significant results adjusted for multiple comparisons are underlined. Results for episodes caused by individual serotypes were compared with the remaining episodes.

c

NT, nontypeable.